Ignite Creation Date:
2025-12-24 @ 12:38 PM
Ignite Modification Date:
2026-04-25 @ 4:16 AM
Study NCT ID:
NCT02767661
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-16
First Post:
2016-05-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
Sponsor:
Organization: